Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

DSpace Repository

Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Author: Beelen, Dietrich W.; Stelljes, Matthias; Remenyi, Peter; Wagner-Drouet, Eva-Maria; Dreger, Peter; Bethge, Wolfgang; Ciceri, Fabio; Stoelzel, Friedrich; Junghanss, Christian; Labussiere-Wallet, Helene; Schaefer-Eckart, Kerstin; Grigoleit, Goetz U.; Scheid, Christof; Patriarca, Francesca; Rambaldi, Alessandro; Niederwieser, Dietger; Hilgendorf, Inken; Russo, Domenico; Socie, Gerard; Holler, Ernst; Glass, Bertram; Casper, Jochen; Wulf, Gerald; Basara, Nadezda; Bieniaszewska, Maria; Stuhler, Gernot; Verbeek, Mareike; La Rocca, Ursula; Finke, Juergen; Benedetti, Fabio; Pichlmeier, Uwe; Klein, Anja; Baumgart, Joachim; Markiewicz, Miroslaw
Tübinger Autor(en):
Bethge, Wolfgang Andreas
Published in: American Journal of Hematology (2022), Bd. 97, H. 8, S. 1023-1034
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1002/ajh.26620
ISSN: 0361-8609
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)